Federal Register - June 9, 2021
Version en texte Qu'est-ce que c'est?Dateas est un site Web indépendant, non affilié à un organisme gouvernemental. La source des documents PDF que nous publions est l'agence officielle indiquée dans chacun d'eux. Les versions en texte sont des transcriptions non officielles que nous faisons pour fournir de meilleurs outils d'accès et de recherche d'informations, mais peuvent contenir des erreurs ou peuvent ne pas être complètes.
Source: Federal Register
Federal Register / Vol. 86, No. 109 / Wednesday, June 9, 2021 / Notices Boulevard, Bethesda, MD 20892 Virtual Meeting.
Contact Person: Ann A. Jerkins, Ph.D., Scientific Review Officer, Review Branch, DEA, NIDDK, National Institutes of Health, Room 7119, 6707 Democracy Boulevard, Bethesda, MD 208925452, 3015942242, jerkinsa@niddk.nih.gov.
Catalogue of Federal Domestic Assistance Program Nos. 93.847, Diabetes, Endocrinology and Metabolic Research;
93.848, Digestive Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology and Hematology Research, National Institutes of Health, HHS
Dated: June 3, 2021.
Miguelina Perez, Program Analyst, Office of Federal Advisory Committee Policy.
BILLING CODE 414001P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health Center for Scientific Review; Notice of Closed Meeting
lotter on DSK11XQN23PROD with NOTICES1
Pursuant to section 10d of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the provisions set forth in sections 552bc4 and 552bc6, Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Biological Chemistry and Macromolecular Biophysics Integrated Review Group; Maximizing Investigators Research Award B Study Section.
Date: July 12, 2021.
Time: 9:00 a.m. to 8:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892 Virtual Meeting.
Contact Person: Sudha Veeraraghavan, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4166, MSC 7846, Bethesda, MD 20892, 301 827
5263, sudha.veeraraghavan@nih.gov.
Information is also available on the Institutes/Centers home page: https
public.csr.nih.gov/StudySections/DBIB/
BCMB, where an agenda and any additional information for the meeting will be posted when available.
18:13 Jun 08, 2021
Jkt 253001
Dated: June 3, 2021.
Miguelina Perez, Program Analyst, Office of Federal Advisory Committee Policy.
FR Doc. 202112027 Filed 6821; 8:45 am BILLING CODE 414001P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health Center for Scientific Review; Amended Notice of Meeting
FR Doc. 202112033 Filed 6821; 8:45 am
VerDate Sep<11>2014
Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333, 93.337, 93.39393.396, 93.83793.844, 93.84693.878, 93.892, 93.893, National Institutes of Health, HHS
Notice is hereby given of a change in the meeting of the Child Psychopathology and Developmental Disabilities Study Section, June 17, 2021, 09:00 a.m. to June 18, 2021, 08:00
p.m., National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892 which was published in the Federal Register on May 20, 2021, 86 FR 27459. Kirk Thompson, Ph.D., Kirk.Thompson@
nih.gov, 240 4989897, will be the new Contact person, replacing Katherine Morasch as Scientific Review Officer.
The meeting date and location remain the same. The meeting is closed to the public.
Dated: June 3, 2021.
Miguelina Perez, Program Analyst, Office of Federal Advisory Committee Policy.
30611
applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Center for Advancing Translational Sciences Special Emphasis Panel; Multi-Disciplinary Machineassisted, Genomic Analysis and Clinical Approaches to Shortening the Rare Diseases Diagnostic Odyssey UG3/UH3 Clinical Trial Optional.
Date: July 14, 2021.
Time: 9:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Center for Advancing Translational Sciences, National Institutes of Health, 6701 Democracy Boulevard, Room 1037, Bethesda, MD 20892 Virtual Meeting.
Contact Person: Nakia C. Brown, Ph.D., Scientific Review Officer, Office of Grants Management and Scientific Review, National Center for Advancing Translational Sciences, National Institutes of Health, 6701
Democracy Boulevard, Room 1037, Bethesda, MD 20892, 3018274905, brownnac@
mail.nih.gov.
Catalogue of Federal Domestic Assistance Program Nos. 93.859, Pharmacology, Physiology, and Biological Chemistry Research; 93.350, BCooperative Agreements; 93.859, Biomedical Research and Research Training, National Institutes of Health, HHS
Dated: June 4, 2021.
David W. Freeman, Program Analyst, Office of Federal Advisory Committee Policy.
FR Doc. 202112093 Filed 6821; 8:45 am BILLING CODE 414001P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
FR Doc. 202112028 Filed 6821; 8:45 am
National Heart, Lung, and Blood Institute; Notice of Meeting
BILLING CODE 414001P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health National Center for Advancing Translational Sciences; Notice of Closed Meeting Pursuant to section 10d of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the provisions set forth in sections 552bc4 and 552bc6, Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant
PO 00000
Frm 00026
Fmt 4703
Sfmt 4703
Pursuant to section 10a of the Federal Advisory Committee Act, as amended, notice is hereby given of a meeting of the National Asthma Education Prevention Program Coordinating Committee.
The meeting will be open to the public, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting.
Name of Committee: National Asthma Education Prevention Program Coordinating Committee.
Date: July 9, 2021.
Time: 11:00 a.m. to 2:00 p.m.
Agenda: To review and discuss asthma guidelines and implementation; updates on current and future activities. Discussion on programmatic updates.
E:FRFM09JNN1.SGM
09JNN1